MedTrace Logo

Development of an HIV Self-testing Intervention

NCT02999243 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 27

Last updated 2020-01-22

No results posted yet for this study

Summary

This randomized controlled trial (RCT) evaluates whether HIV self-testing (HIVST) facilitates sexual harm reduction and reduces HIV transmission among HIV-negative MSM in China.The intervention group will be offered HIVST kits plus harm reduction education, and followed 9 month, while the control group will receive harm reduction educational material only.

Conditions

  • HIV Serosorting

Interventions

BEHAVIORAL

HIV self-testing

The intervention group will be offered HIV self-testing kits for testing HIV status

BEHAVIORAL

Harm reduction education

Both arms will receive harm reduction education

Sponsors & Collaborators

Principal Investigators

  • Chongyi Wei, DrPH · University of California, San Francisco

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-08-15
Primary Completion
2018-05-21
Completion
2018-05-21

Countries

  • China

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02999243 on ClinicalTrials.gov